These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23095807)

  • 1. Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields.
    Rulseh AM; Keller J; Klener J; Sroubek J; Dbalý V; Syrůček M; Tovaryš F; Vymazal J
    World J Surg Oncol; 2012 Oct; 10():220. PubMed ID: 23095807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
    Vymazal J; Wong ET
    Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.
    Burri SH; Gondi V; Brown PD; Mehta MP
    Am J Clin Oncol; 2018 Feb; 41(2):191-196. PubMed ID: 28832384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
    Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
    Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapy.
    Kanner AA; Wong ET; Villano JL; Ram Z;
    Semin Oncol; 2014 Oct; 41 Suppl 6():S25-34. PubMed ID: 25213871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.
    Hu LS; Eschbacher JM; Heiserman JE; Dueck AC; Shapiro WR; Liu S; Karis JP; Smith KA; Coons SW; Nakaji P; Spetzler RF; Feuerstein BG; Debbins J; Baxter LC
    Neuro Oncol; 2012 Jul; 14(7):919-30. PubMed ID: 22561797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent glioblastoma: who receives tumor specific treatment and how often?
    Steffens R; Semrau S; Lahmer G; Putz F; Lettmaier S; Eyüpoglu I; Buchfelder M; Fietkau R
    J Neurooncol; 2016 May; 128(1):85-92. PubMed ID: 26907492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.
    Straube C; Elpula G; Gempt J; Gerhardt J; Bette S; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    Strahlenther Onkol; 2017 Nov; 193(11):897-909. PubMed ID: 28616821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept.
    Bräutigam E; Lampl C; Track C; Nieder C; Pichler J; Hammer J; Geinitz H
    Clin Transl Oncol; 2019 May; 21(5):582-587. PubMed ID: 30284233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A feasibility study of the Nativis Voyager
    Murphy M; Dowling A; Thien C; Priest E; Morgan Murray D; Kesari S
    CNS Oncol; 2019 Mar; 8(1):CNS31. PubMed ID: 30727742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
    J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic glioblastoma multiforme: survival outcomes in 22 cases.
    Maldaun MV; Suki D; Lang FF; Prabhu S; Shi W; Fuller GN; Wildrick DM; Sawaya R
    J Neurosurg; 2004 Jan; 100(1):61-7. PubMed ID: 14743913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.
    Zolal A; Juratli TA; Linn J; Podlesek D; Sitoci Ficici KH; Kitzler HH; Schackert G; Sobottka SB; Rieger B; Krex D
    J Neurooncol; 2016 May; 127(3):551-7. PubMed ID: 26830088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma.
    Omar AI
    J Vis Exp; 2014 Oct; (92):e51638. PubMed ID: 25407354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in glioblastoma survival by case volume: a nationwide observational study.
    Raj R; Seppä K; Luostarinen T; Malila N; Seppälä M; Pitkäniemi J; Korja M
    J Neurooncol; 2020 Apr; 147(2):361-370. PubMed ID: 32060840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-treating fields: time for demystification.
    Weller M
    Ann Oncol; 2018 Aug; 29(8):1628-1630. PubMed ID: 29905756
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients.
    Socha J; Kepka L; Ghosh S; Roa W; Kumar N; Sinaika V; Matiello J; Lomidze D; de Castro DG; Hentati D; Fidarova E
    J Neurooncol; 2016 Feb; 126(3):493-8. PubMed ID: 26542030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant astrocytic gliomas in children.
    Marchese MJ; Chang CH
    Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
    Shi W; Blumenthal DT; Oberheim Bush NA; Kebir S; Lukas RV; Muragaki Y; Zhu JJ; Glas M
    J Neurooncol; 2020 Jul; 148(3):489-500. PubMed ID: 32535723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
    Lee J; Ahn SS; Chang JH; Suh CO
    Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.